Trifluoperazine dihydrochloride
| Code | Size | Price |
|---|
| TAR-T1222-100mg | 100mg | £111.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Trifluoperazine Dihydrochloride is a potent dopamine D2 receptor inhibitor used as an antipsychotic and an antiemetic.
CAS:
440-17-5
Formula:
C21H26Cl2F3N3S
Molecular Weight:
480.42
Pathway:
Membrane transporter/Ion channel; Microbiology/Virology; Neuroscience; GPCR/G Protein; Autophagy
Purity:
0.9996
SMILES:
Cl.Cl.CN1CCN(CCCN2c3ccccc3Sc3ccc(cc23)C(F)(F)F)CC1
Target:
CaMK; Dopamine Receptor; Influenza Virus; Adrenergic Receptor; P-gp; Autophagy
References
1. Lahti RA, et al. Eur J Pharmacol, 1993, 236(3), 483-486.
2. Cahir M, et al. Eur Neuropsychopharmacol, 2005, 15(2), 231-234.
3. Madrid PB, et al. Bioorg Med Chem Lett, 2007, 17(11), 32014-32017.
4. Won SJ, et al. Experientia, 1995, 51(4), 343-348.
5. Motohashi N, et al. Curr Drug Targets, 2000, 1(3), 237-245.